Open AccessAntimicrobial stewardship program in COVID-19 era: Ruin of the reign?
Author(s) -
Arash Eatemadi,
Sirous Golchinheydari,
Mohammed Al Reesi,
Majid Al Maqbali,
Talib Al Maqbali,
Aiman Al Wahaibi
Publication year - 2021
Publication title -
journal of biomedical and pharmaceutical research
Language(s) - English
Resource type - Journals
eISSN - 2589-8752
pISSN - 2279-0594
DOI - 10.32553/jbpr.v9i6.822
Subject(s) - covid-19 , stewardship (theology) , antimicrobial stewardship , antibiotic stewardship , antibiotics , medical prescription , reign , medicine , pandemic , intensive care medicine , disease , infectious disease (medical specialty) , virology , political science , antibiotic resistance , microbiology and biotechnology , nursing , biology , outbreak , politics , law
COVID-19 is the most important matter in the medical field worldwide in 2020. Although COVID-19 is a viral disease, the threshold to antibiotic prescription for COVID-19 patients is low, partly because of WHO recommendations and previous experiences from influenza, despite the lack of strong evidence of co-infection or superimposed bacterial infection in COVID-19 patients. Antibiotic stewardship program (ASP) could play an important role in this period, otherwise, we will face a crisis of superbugs in the early future.
Keywords: COVID-19, Antibiotic stewardship program (ASP), Superbugs